MHC recognition by hapten-specific HLA-A2-restricted CD8+ CTL. 2003

Susan J Gagnon, and Zichun Wang, and Richard Turner, and Marale Damirjian, and William E Biddison
Molecular Immunology Section, Neuroimmunology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892, USA.

T cell recognition by peptide-specific alphabeta TCRs involves not only recognition of the peptide, but also recognition of multiple molecular features on the surface of the MHC molecule to which the peptide has been bound. We have previously shown that TCRs that are specific for five different peptides presented by HLA-A2 recognize similar molecular features on the surface of the alpha1 and alpha2 helices of the HLA-A2 molecule. We next asked whether these same molecular features of the HLA-A2 molecule would be recognized by hapten-specific HLA-A2-restricted TCRs, given that hapten-specific T cells frequently show reduced MHC dependence/restriction. The results show that a panel of CD8+ CTL that are specific for the hapten DNP bound to two different peptides presented by HLA-A2 do the following: 1) show stringent MHC restriction, and 2) are largely affected by the same mutations on the HLA-A2 molecule that affected recognition by peptide-specific CTL. A small subset of this panel of CD8+ CTL can recognize a mutant HLA-A2 molecule in the absence of hapten. These data suggest that TCR recognition of a divergent repertoire of ligands presented by HLA-A2 is largely dependent upon common structural elements in the central portion of the peptide-binding site.

UI MeSH Term Description Entries
D008239 Lysine An essential amino acid. It is often added to animal feed. Enisyl,L-Lysine,Lysine Acetate,Lysine Hydrochloride,Acetate, Lysine,L Lysine
D010446 Peptide Fragments Partial proteins formed by partial hydrolysis of complete proteins or generated through PROTEIN ENGINEERING techniques. Peptide Fragment,Fragment, Peptide,Fragments, Peptide
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D002462 Cell Membrane The lipid- and protein-containing, selectively permeable membrane that surrounds the cytoplasm in prokaryotic and eukaryotic cells. Plasma Membrane,Cytoplasmic Membrane,Cell Membranes,Cytoplasmic Membranes,Membrane, Cell,Membrane, Cytoplasmic,Membrane, Plasma,Membranes, Cell,Membranes, Cytoplasmic,Membranes, Plasma,Plasma Membranes
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D003602 Cytotoxicity, Immunologic The phenomenon of target cell destruction by immunologically active effector cells. It may be brought about directly by sensitized T-lymphocytes or by lymphoid or myeloid "killer" cells, or it may be mediated by cytotoxic antibody, cytotoxic factor released by lymphoid cells, or complement. Tumoricidal Activity, Immunologic,Immunologic Cytotoxicity,Immunologic Tumoricidal Activities,Immunologic Tumoricidal Activity,Tumoricidal Activities, Immunologic
D004136 Dinitrobenzenes Benzene derivatives which are substituted with two nitro groups in the ortho, meta or para positions. Dinitrobenzene,Dinitrophenyl Compound,Dinitrophenyl Compounds,Dinitrotoluene,Dinitrotoluenes,Compound, Dinitrophenyl
D006241 Haptens Small antigenic determinants capable of eliciting an immune response only when coupled to a carrier. Haptens bind to antibodies but by themselves cannot elicit an antibody response. Hapten,Contact-Sensitizing Agents,Agents, Contact-Sensitizing,Contact Sensitizing Agents
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Susan J Gagnon, and Zichun Wang, and Richard Turner, and Marale Damirjian, and William E Biddison
July 1986, Journal of immunology (Baltimore, Md. : 1950),
Susan J Gagnon, and Zichun Wang, and Richard Turner, and Marale Damirjian, and William E Biddison
September 2001, Journal of immunology (Baltimore, Md. : 1950),
Susan J Gagnon, and Zichun Wang, and Richard Turner, and Marale Damirjian, and William E Biddison
November 2001, Cancer immunology, immunotherapy : CII,
Susan J Gagnon, and Zichun Wang, and Richard Turner, and Marale Damirjian, and William E Biddison
May 2023, European journal of immunology,
Susan J Gagnon, and Zichun Wang, and Richard Turner, and Marale Damirjian, and William E Biddison
May 2002, Journal of clinical immunology,
Susan J Gagnon, and Zichun Wang, and Richard Turner, and Marale Damirjian, and William E Biddison
September 2002, Journal of immunology (Baltimore, Md. : 1950),
Susan J Gagnon, and Zichun Wang, and Richard Turner, and Marale Damirjian, and William E Biddison
January 2005, World journal of gastroenterology,
Susan J Gagnon, and Zichun Wang, and Richard Turner, and Marale Damirjian, and William E Biddison
January 2005, Methods in molecular medicine,
Susan J Gagnon, and Zichun Wang, and Richard Turner, and Marale Damirjian, and William E Biddison
October 2005, Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology,
Susan J Gagnon, and Zichun Wang, and Richard Turner, and Marale Damirjian, and William E Biddison
June 1997, Cellular immunology,
Copied contents to your clipboard!